Corp-Ethics.com - Report: Fined for Medicaid Fraud

Company	AstraZeneca [Company Info]
	Track this Company (an email will be sent to you everytime a report is filed about this company)

Date	Issue	Title
27th Jan 2004	Fraud Investigation	Fined for Medicaid Fraud

Report

Florida's Medicaid program will receive $807,826 from pharmaceutical company AstraZeneca as a result of a settlement with the attorney general.

Attorney General Charlie Crist says the company committed Medicaid fraud through the marketing and sale of the drug Zoladex for use in the treatment of prostate cancer.

Crist says AstraZeneca overcharged Medicaid for Zoladex by not including promotions, free goods, discounts, rebates and other reductions in the price paid by Medicaid. The settlement period covers Jan. 1, 1993, through Dec. 31, 2003.

"We will not let our citizens be taken to the cleaners by companies that cheat taxpayer-funded programs," Crist said in a prepared statement. "This case is about greed and taking advantage of those who have no choice in the medications they purchase."

The attorney general's Medicaid Fraud Control Unit recovered more than $27 million in taxpayer funds last year.

Other Reports on AstraZeneca
Date	Issue	Company	Report
20th May 2004	Questionable Practice	AstraZeneca	Group Sues Astra Zeneca
20th Jun 2003	Fraud Investigation	AstraZeneca	$355m fraud fine

Related Reports from the Pharamaceutical Industry
Company	Issue	Report
Pfizer	Questionable Practice	Group sues Pfizer, other drug makers over imports
GlaxoSmithKline	Questionable Practice	Glaxo drops appeal in Aids drug pricing case
GlaxoSmithKline	Other Issue	Glaxo shares dip on factory probe
Pfizer	Questionable Practice	Pfizer claims Britons denied treatment
GlaxoSmithKline	Other Issue	New York sues GlaxoSmithKline